News
-
Rethink dispensary
Wednesday | Apr 24 2024WILLACH Consis.C provides the latest in robotic automation for a more efficient dispensary set-up, freeing up space and time.
-
Dispensary Corner 24 Apr 24
Wednesday | Apr 24 2024YOU know its bad when health experts feel the need to issue a warning to young Aussies to remind them that TikTok is not the best place to turn to for medical advice.
-
Hartley’s Gripe Water
Wednesday | Apr 24 2024HARTLEY'S Gripe Water is a natural blend of herbal ingredients of Dill Seed Oil, Peppermint Oil, Chamomile and Coriander Oil.
-
MDR’s results surpass expectations
Tuesday | Apr 23 2024MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
-
Call to restructure CSO
Tuesday | Apr 23 2024PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
-
Camden takes top spot
Tuesday | Apr 23 2024CAMDEN Day and Night Pharmacy has clinched the top prize in the Pharmacy category at the 2024 Australian Small Business Champion Awards recently.
-
Locumate expands to US
Tuesday | Apr 23 2024AUSTRALIAN start-up Locumate.ai has partnered with the Californian and American Pharmacist Associations to launch a new joint venture called HealthShifts, aimed at changing the on-demand workforce for pharmacists in North America.
-
Save and fly soon
Tuesday | Apr 23 2024POINTRS is offering people ways to save money on travel by using cash, credit card and loyalty points.
-
PATY entries call
Tuesday | Apr 23 2024GUILD President Trent Twomey has reminded pharmacy owners and managers that nominations for the Maxigesic Pharmacy Assistant of the Year Award (PATY) will close on 10 May.
-
Wellnex Life gets dual-listing on LSE
Tuesday | Apr 23 2024WELLNEX Life, Australian consumer healthcare company, has announced today its decision to pursue a dual listing on the London Stock Exchange (LSE), with the aim of accelerating its international expansion.